Cross-subtype immunity against avian influenza in persons recently vaccinated for influenza

Emerging Infectious Diseases

Volumn 14, Issue 1, 2008, Pages 121-128

  Gioia, Cristiana ^a   Castilletti, Concetta ^a   Tempestilli, Massimo ^a   Piacentini, Paola ^a   Bordi, Licia ^a   Chiappini, Roberta ^a   Agrati, Chiara ^a   Squarcione, Salvatore ^a   Ippolito, Giuseppe ^a   Puro, Vincenzo ^a   Capobianchi, Maria R ^a   Poccia, Fabrizio ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INFLUENZA VACCINE;

ADULT; ANIMAL CELL; ARTICLE; AVIAN INFLUENZA; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; FATALITY; FEMALE; HUMAN; HUMORAL IMMUNITY; IMMUNITY; INFLUENZA VACCINATION; INFLUENZA VIRUS A; INFLUENZA VIRUS A H5N1; MALE; NONHUMAN; VIRUS STRAIN; VIRUS TRANSMISSION; VIRUS TYPING; VIRUS VIRULENCE;

EID: 38049048628     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1401.061283     Document Type: Article

References (32)

1. Monto AS, Ohmit SE, Margulies JR, Talsma A. Medical practice-based influenza surveillance: viral prevalence and assessment of morbidity. Am J Epidemiol. 1995;141:502-6.
2. Moriuchi H, Katsushima N, Nishimura H, Nakamura K, Numazaki Y. Community-acquired influenza C virus infection in children. J Pediatr. 1991;118:235-8.
3. Cox NJ, Subbarao K. Global epidemiology of influenza: past and present. Annu Rev Med. 2000;51:407-21.
4. Collins SD, Lehmann J. Trends and epidemics of influenza and pneumonia: 1918-1951. Public Health Rep. 1951;66:1487-516.
5. Ada GL, Jones PD. The immune response to influenza infection. Curr Top Microbiol Immunol. 1986;128:1-54.
6. Jameson J, Cruz J, Ennis FA. Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol. 1998;72:8682-9.
7. Couch RB, Kasel JA. Immunity to influenza in man. Annu Rev Microbiol. 1983;37:529-49.
8. Flynn KJ, Belz GT, Altman JD, Ahmed R, Woodland DL, Doherty PC. Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. Immunity. 1998;8:683-91.
9. Rimmelzwaan GF. Osterhaus AD. Cytotoxic T lymphocyte memory: role in cross-protective immunity against influenza? Vaccine. 1995;13:703-5.
10. O'Neill E, Krauss SL, Riberdy JM, Webster RG, Woodland DL. Heterologous protection against lethal A/HongKong/156/97 (H5N1) influenza virus infection in C57BL/6 mice. J Gen Virol. 2000;81:2689-96.
11. Kilbourne ED. Influenza pandemics of the 20th century. Emerg Infect Dis. 2006;12:9-14.
12. Epstein SL. Prior H1N1 influenza infection and susceptibility of Cleveland Family Study participants during the H2N2 pandemic of 1957: an experiment of nature. J Infect Dis. 2006;193:49-53.
13. Seo SH, Webster RG. Cross-reactive, cell-mediated immunity and protection of chickens from lethal H5N1 influenza virus infection in Hong Kong poultry markets. J Virol. 2001;75:2516-25.
14. Jameson J, Cruz J, Terajima M, Ennis FA. Human CD8+ and CD4+ T lymphocyte memory to influenza A viruses of swine and avian species. J Immunol. 1999;162:7578-83.
15. Chan PK. Outbreak of avian influenza A(H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002;34(Suppl 2):S58-64.
16. World Organization for Animal Health (OIE). Manual of diagnostic tests and vaccines for terrestrial animals, 5th ed. 2004 [cited 2006 Feb 2]. Available from http://www.oie.int/eng/normes/mmanual/a_00037.htm
17. Reed LJ, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg. 1938;27:493-7.
18. McShane H, Pathan AA, Sander CR, Keating SM, Gilbert SC, Huygen K, et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med. 2004;10:1240-4.
19. Gioia C, Horejsh D, Agrati C, Martini F, Capobianchi MR, Ippolito G, et al. T-cell response profiling to biological threat agents including the SARS coronavirus. Int J Immunopathol Pharmacol. 2005;18:525-30.
20. Harmon MW, Rota PA, Walls HH, Kendal AP. Antibody response in humans to influenza virus type B host-cell-derived variants after vaccination with standard (egg-derived) vaccine or natural infection. J Clin Microbiol. 1988;26:333-7.
21. World Health Organization. WHO manual on animal influenza diagnosis and surveillance. Geneva: The Organization; 2002. Document WHO/CDS/CSR/NCS/2002.5.
22. US Department of Health and Human Services. Pandemic influenza plan. 2006 [cited 2006 Feb 2]. Available from http://www.hhs.gov/pandemicflu/plan/sup2. html
23. Richmond JY, Nesby-O'Dell SL. Laboratory security and emergency response guidance for laboratories working with select agents. MMWR Recomm Rep. 2002;51:1-6.
24. Webster RG, Askonas BA. Cross-protection and cross-reactive cytotoxic T cells induced by influenza virus vaccines in mice. Eur J Immunol. 1980;10:396-401.
25. LaSalle JM, Hafler DA. T cell anergy. FASEB J. 1994;8:601-8.
26. Sandbulte MR, Jimenez GS, Boon AC, Smith LR, Treanor JJ, Webby RJ. Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans. PLoS Med. 2007;4:e59.
27. Lee BO, Rangel-Moreno J, Moyron-Quiroz JE, Hartson L, Makris M, Sprague F, et al. CD4 T cell-independent antibody response promotes resolution of primary influenza infection and helps to prevent reinfection. J Immunol. 2005;175:5827-38.
28. Sangster MY, Riberdy JM, Gonzalez M, Topham DJ, Baumgarth N, Doherty PC. An early CD4+ T cell-dependent immunoglobulin A response to influenza infection in the absence of key cognate T-B interactions. J Exp Med. 2003;198:1011-21.
29. Oxenius A, Zinkernagel RM, Hengartner H. CD4+ T-cell induction and effector functions: a comparison of immunity against soluble antigens and viral infections. Adv Immunol. 1998;70:313-67.
30. Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993;11:331-60.
31. Sha Z, Compans RW. Induction of CD4(+) T-cell-independent immunoglobulin responses by inactivated influenza virus. J Virol. 2000;74:4999-5005.
32. Smallman-Raynor M, Cliff AD. Avian influenza A (H5N1) age distribution in humans. Emerg Infect Dis. 2007;13:510-2.